NUS
Nu Skin Enterprises, Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$4.84
+2.98%Year over year
Reported trailing growth
- Revenue
- -15.4%
- EBITDA
- -80.0%
- EBIT
- +38.7%
- EPS
- —
- Free cash flow
- -81.6%
- Operating cash flow
- -45.6%
Forward estimates
Based on analyst estimates
- Revenue
- +1.0%
- EBITDA
- +227.6%
- EPS
- +121.6%
Three-year CAGR
- Revenue
- -12.6%
- EBITDA
- +14.5%
- EBIT
- -6.4%
- Net income
- +15.2%
- EPS
- +15.7%
- Free cash flow
- -2.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026